Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05723653 · ClinicalTrials.gov registry record · NA
Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention
A NA study of HIV Seropositivity, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 900
- Enrollment target
- 7
- Study locations
NCT05723653 is a NA study of HIV Seropositivity that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 900 participants, above the 184-participant average among 4 other HIV Seropositivity trials with a reported enrollment target (389% higher). The trial reports 7 study locations across 3 states.
The verdict
NCT05723653, a NA study of HIV Seropositivity, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 900 participants
- Enrollment target
- 7
- Study locations
Study Summary
The goal of this Hybrid Type I effectiveness-implementation trial is to test an evidence-based, flexible, and tailored intervention that leverages existing social network members to promote retention in care and viral suppression among people living with HIV aged 18-49.
Conditions Studied
Interventions
- BEHAVIORAL Social Network Support Intervention
Study Locations (7)
Alabama
- University of Alabama at Birmingham 1917 Clinic - Birmingham
- Birmingham AIDS Outreach - Birmingham
- Thrive Alabama - Huntsville
Illinois
- Howard Brown Health - Chicago
- Chicago Center for HIV Elimination - Chicago
- Crown Family School of Social Work, Policy, and Practice at the University of Chicago - Chicago
Louisiana
- Tulane University - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2023-02-13 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05723653
The ClinicalTrials.gov registry entry for NCT05723653 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 184-participant average among 4 other HIV Seropositivity trials with a reported enrollment target (389% higher). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Seropositivity appearing as the primary indexed condition, and to 1 intervention - of which Social Network Support Intervention is the first listed.
NCT05723653 reports 7 study locations spanning 3 distinct geographic areas - top geographies include Alabama, Illinois, Louisiana.
Frequently Asked Questions
What is clinical trial NCT05723653 about?
NCT05723653 is a clinical study titled "Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention". The goal of this Hybrid Type I effectiveness-implementation trial is to test an evidence-based, flexible, and tailored intervention that leverages existing social network members to promote retention in care and viral suppression among people living with HIV aged 18-49.
What is the current status of trial NCT05723653?
This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2023-02-13. Estimated completion is 2027-12-31.
What conditions does trial NCT05723653 study?
This clinical trial studies the following conditions: HIV Seropositivity.
What interventions are being tested in trial NCT05723653?
The interventions under investigation include: Social Network Support Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05723653?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05723653 being conducted?
This trial has 7 study locations across Alabama, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Seropositivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessing the PrEP Care Cascade Among Black Men and Transwomen in the Southeastern US
ACTIVE NOT RECRUITING · NA
-
The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART
COMPLETED · Phase 2
-
Safer Conception Intervention for HIV-1 Serodiscordant Couples
COMPLETED
-
Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.